Airway drug pharmacokinetics via analysis of exhaled breath condensate. - Wikidata - awgldk - TriplyDB

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

http://www.wikidata.org/entity/Q37625778

about

Exhaled Breath Condensate: Technical and Diagnostic Aspects Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.Variability of the Sheep Lung Microbiota.

P2860

Q28082250-1472A462-40F6-4FE0-B5BE-6B6B7B7EC8EA Q34748891-DEEA2603-BBD4-4E8C-ABD0-42E597CBFE13 Q37122357-C6E286B7-E3F8-492B-98C4-A51E7C014302

P2860

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

http://www.wikidata.org/entity/Q37625778

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

@en

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

@nl

type

label

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

@en

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

@nl

prefLabel

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

@en

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

@nl

P1433

Q37625778-3D991474-F7E3-4FBB-9084-CADC5F83D66F

P1476

Q37625778-3DE063AE-FDC7-4307-8358-77465D1C95E6

P2093

Q37625778-196E620D-4428-4794-8FD3-863B0B72D2AC

Q37625778-4D676546-882A-4260-BB6B-2E165DFA9AA5

Q37625778-5BD4F742-A668-4CB1-9505-7E1A15ACB97C

Q37625778-8719C6CC-FC66-4729-A9F5-294119FAEDB4

Q37625778-99B25BBE-82CB-48CF-A913-60EC889AAB58

Q37625778-CB412508-9049-424F-95A1-29C63A3625DF

Q37625778-DD8F70CE-E492-42BA-96B6-D83438388C60

Q37625778-E9977744-81BE-402A-97C7-50751F129E22

P2860

Q37625778-3F317373-9DF5-4E17-8002-8F8BAB2DC6D3

Q37625778-41D9497F-39E0-44B7-80E1-B1B53D38AD5E

Q37625778-43D1F65E-84FF-4E11-B1EB-BA3CE554AE49

Q37625778-4F44DF8C-C3E1-4557-8F4A-EC5C733A2E02

Q37625778-5718CF5C-CAEF-48B9-82E6-0C2D5CBE9A8B

Q37625778-65791C50-49C0-4285-B5A5-5306DC96EEBF

Q37625778-69739643-73D0-4E7C-B52D-485F406D5292

Q37625778-6C9BADD3-1840-4169-A66A-DCD1270FC330

Q37625778-754A6A9B-CE44-46DE-8F32-17C8378227FB

Q37625778-756C56A0-3742-4AA0-9167-0719F2A4AB5F

P304

Q37625778-62A23665-2934-47EB-B9ED-6054A670DD64

P31

Q37625778-F62DBBFF-9FB7-427C-BF79-B52E82C22F80

P356

Q37625778-49E722B7-2486-41F4-91E6-FFDFD2645856

P433

Q37625778-C6BFCB8C-C095-4DAD-BB86-C071CCC7593A

P478

Q37625778-C8815A48-E60F-49F3-A9BE-9B4648B2E6C1

P577

Q37625778-3A16D791-43A1-4724-A84A-A283A049CCEA

P698

Q37625778-519D4003-8C58-4F5D-828D-CEE6B332545C

P921

Q37625778-AFB414B3-7BC1-4D7E-9D69-96CE7BFD26A6

P932

Q37625778-0DA7B6A5-4734-4D15-94AF-633C5209EE21

P356

J.PUPT.2013.07.009

P1433

Pulmonary Pharmacology & Therapeutics

P1476

Airway drug pharmacokinetics via analysis of exhaled breath condensate.

@en

P2093

Andrew J Ghio

http://www.w3.org/2001/XMLSchema#string

Andrew J Hirsh

http://www.w3.org/2001/XMLSchema#string

Charles R Esther

http://www.w3.org/2001/XMLSchema#string

John H Ansede

http://www.w3.org/2001/XMLSchema#string

Karl H Donn

http://www.w3.org/2001/XMLSchema#string

M Ross Johnson

http://www.w3.org/2001/XMLSchema#string

Richard C Boucher

http://www.w3.org/2001/XMLSchema#string

Thomas G O'Riordan

http://www.w3.org/2001/XMLSchema#string

P2860

The mechanism of breath aerosol formation

The nature of small-airway obstruction in chronic obstructive pulmonary disease

Characterization of exhaled particles from the healthy human lung--a systematic analysis in relation to pulmonary function variables.

Drug-induced hyperkalemia: old culprits and new offenders.

Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.

Airway purinergic responses in healthy, atopic nonasthmatic, and atopic asthmatic subjects exposed to ozone.

Elevated airway purines in COPD.

The promise and perils of exhaled breath condensates.

Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH.

Exhaled breath condensate purines correlate with lung function in infants and preschoolers

P304

76-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PUPT.2013.07.009

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23932897

http://www.w3.org/2001/XMLSchema#string

P921

P932

3947122

http://www.w3.org/2001/XMLSchema#string